Work

Relief of bowel-related symptoms with telotristat etiprate in octreotide refractory carcinoid syndrome: Preliminary results of a placebo-controlled, multicenter study.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.4_suppl.312

Authors: Thomas M. O'Dorisio, Alexandria T. Phan, Robert M. Langdon, Billie J. Marek, Nadeem Ikhlaque, Emily K. Bergsland, Joel Freiman, Linda Law, Phillip Lee Banks, Kenneth Frazier, Jessica Jackson, Brian Zambrowicz, Matthew Kulke

Institutions: The University of Texas MD Anderson Cancer Center, University of California, San Francisco, University of Iowa Hospitals and Clinics, Lexicon Pharmaceuticals (United States), Methodist Hospital, St. Francis Hospital, UCSF Helen Diller Family Comprehensive Cancer Center

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4242992322

Cites:

Cited by: 2

Related to: 10